Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients
Both IL-40 and sCD40L are significantly elevated in MS and exhibit promising diagnostic validity. These biomarkers may serve as complementary tools for monitoring MS disease activity and progression, offering potential value in clinical practice and therapeutic decision-making.
Authors
- Inas K. Sharquie (ORCID: https://orcid.org/0000-0002-4953-7365)
- Gheyath Al Gawwam (ORCID: https://orcid.org/0000-0002-5614-7680)
- Mustafa Ziyad NEAMAH
Institutions
- University of Baghdad (IQ)
Publication Details
- Journal
- Medeniyet Medical Journal
- Published
- 2025-12-31
- DOI
- https://doi.org/10.4274/mmj.galenos.2025.48830
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00